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The bHLH transcription factor SCL plays a central role in the generation of hematopoietic cells in vertebrates. We modified a PAC containing the
whole zebrafish scl locus, inserting GFP into the first coding exon of scl. In germline-transgenic zebrafish generated using this construct, GFP
expression completely recapitulates the endogenous expression of scl in blood, endothelium and CNS. We performed in vivo timelapse imaging of
blood and endothelial precursor migration at the single-cell level and show that these cells migrate from the posterior lateral plate mesoderm to their
site of differentiation in the intermediate cell mass. The anterior lateral plate domain of GFP expression gives rise to primitive macrophages and the
blood vessels of the head. In later embryos, GFP expression identifies clusters of hematopoietic cells that develop between the dorsal aorta and
posterior cardinal veins after primitive erythrocytes have entered circulation. Two treatments that block definitive hematopoiesis (treatment with
dioxin (TCDD), and injection of an antisense morpholino oligonucleotide targeted to runx1) ablate these hematopoietic clusters. This indicates that
these clusters represent the first site of definitive hematopoiesis in zebrafish. This site is anatomically homologous to the proposed source of
hematopoietic stem cells in amniotes, the aorta–gonad–mesonephros (AGM) region. A second transgenic line, containing the promoter of scl driving
GFP, lacks expression in the definitive clusters.
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Hematopoiesis in vertebrate embryos occurs in two waves:
primitive and definitive (reviewed in Godin and Cumano,
2002). Primitive hematopoiesis gives rise to erythrocytes and
phagocytes in the early embryo, and does not appear to involve
self-renewing hematopoietic stem cells (HSC). Subsequently,
definitive hematopoiesis gives rise to HSC, which generate the
full range of blood cell types in the later embryo and through-
out adulthood. Primitive and definitive cells appear to have
separate embryonic origins (Ciau-Uitz et al., 2000; Dieterlen-
Lievre, 1975).
In amniotes, the site of primitive hematopoiesis is the yolk
sac. The primitive erythrocytes and yolk sac vasculature form⁎ Corresponding author. Fax: +44 20 7848 6435.
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doi:10.1016/j.ydbio.2007.04.002from ‘hematic cords’ of extraembryonicmesoderm (Sabin, 1920),
which led Murray (1932) to coin the term ‘hemangioblast’, for a
proposed bipotential progenitor cell for endothelial cell (EC) and
blood cell formation.
The zebrafish is becoming an increasingly important model
for the study of blood development (reviewed in Davidson and
Zon, 2004). Its transparency, and development outside the
mother, allow in vivo studies that are impractical in amniote
embryos. In zebrafish, primitive hematopoiesis is also closely
associated with endothelial development. Erythroblasts are
formed in the intermediate cell mass (ICM) of the trunk
(between the paired somites, ventral to the notochord, and dorsal
to the endoderm) (Al-Adhami and Kunz, 1977). This tissue also
forms the major vessels of the trunk: the dorsal aorta (DA) and
posterior cardinal vein (PCV). Primitive macrophages emerge
from the anterior lateral mesoderm (ALM) adjacent to the
midbrain (Herbomel et al., 1999), a region that is also thought to
contribute to the head vasculature.
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later found in the ICM is initiated in the posterior lateral
mesoderm (PLM) (Brown et al., 2000; Detrich et al., 1995;
Fouquet et al., 1997; Gering et al., 1998). Themovement of these
expression domains to the midline is generally thought to result
from cell migration. However, gene expression is dynamically
regulated during this process. Genes that are later confined to
either the blood or the endothelium are initially co-expressed in
lateral stripes in the PLM (Brown et al., 2000; Gering et al.,
1998), and as the expression domains move from the lateral
mesoderm to the ICM, a progressive separation of blood and
endothelial gene expression occurs. Therefore, while strongly
suggestive, movement of gene expression does not prove cell
movement. There is only limited direct evidence for such
migration: Childs et al. (2002) showed that patches of cells in the
PLM, in which a caged fluorescein marker had been activated
using a laser, could give rise to cells in the axial vasculature.
Therefore, in this study, we have imaged migration of PLM cells
at single-cell resolution in living zebrafish embryos.
The site of formation of the first definitive HSCs is still the
subject of controversy. In amniotes, most evidence points to an
intraembryonic site, the aorta–gonad–mesonephros (AGM)
region (Godin et al., 1993, 1995; Medvinsky and Dzierzak,
1996; Medvinsky et al., 1993; Muller et al., 1994), from which
later sites of blood formation, such as the fetal liver are
colonized. However, extraembryonic sites for HSC formation,
such as the yolk sac (Kumaravelu et al., 2002) and allantois,
cannot definitively be ruled out. Within the AGM, clusters of
presumptive hematopoietic cells are found in association with
the ventral wall of the aorta (Emmel, 1916; Garcia-Porrero et al.,
1995; Tavian et al., 1996). Tissue transplants (Pardanaud et al.,
1996), in vivo labeling (Jaffredo et al., 1998) and marker-based
sorting (de Bruijn et al., 2002; Nishikawa et al., 1998a,b) imply
that hematopoietic cells are derived from the endothelium of the
aorta: the ‘hemogenic endothelium’ hypothesis. Other experi-
ments, however, suggest that the definitive HSCs might arise in
mesenchyme ventral to the DA, and pass through the ventral
wall of the DA to form the hematopoietic clusters (Bertrand
et al., 2005; North et al., 2002). These two possibilities are not,
however, mutually exclusive (Jaffredo et al., 2000).
In zebrafish, definitive hematopoiesis is poorly understood
compared to primitive hematopoiesis. Primitive erythrocytes
(which enter circulation at around 26 hpf) are gradually lost from
circulation from 5 days post fertilization (dpf) (Weinstein et al.,
1996), and are replaced by a population morphologically more
similar to adult erythrocytes (Belair et al., 2001). Lymphocytes
(which are regarded as a definitive cell type) are first detected in
the thymus around 3 dpf (Willett et al., 1997, 1999). Cells with
the morphology of hematopoietic blasts are found in the
pronephric kidney (the site of adult hematopoiesis) from 4 dpf
(Al-Adhami and Kunz, 1977; Willett et al., 1999). These data
imply that definitive hematopoiesis initiates in the second or
third day of development. Transcription factors implicated in
definitive hematopoiesis in amniotes, including c-myb, ikaros
and runx1 (AML1), are expressed in the ICM region after the
primitive erythroblasts have entered circulation (Burns et al.,
2002; Gering and Patient, 2005; Kalev-Zylinska et al., 2002;Thompson et al., 1998; Willett et al., 2001). Interestingly, the
expression of these genes initiates in the floor of the DA,
implying that this may be hemogenic endothelium. Further
evidence that these cells may be involved in definitive
hematopoiesis in zebrafish is provided by morpholino oligonu-
cleotide (MO)-mediated knockdown of runx1 expression. This
results in the loss of c-myb and ikaros expression in the floor of
the DA and reduction or loss of lymphocytes in the thymus
(Gering and Patient, 2005). An alternative site suggested is the
ventral part of the post anal ICM, also called the ventral vein
region (VVR), based on the prolonged expression of scl and c-
myb in this area (Liao et al., 1998).
We have previously shown that bHLH transcription factor scl
is one of the earliest markers of the cells in PLM that are thought
to give rise to the ICM (Gering et al., 1998). In mice, SCL (also
known as TAL1) plays a key role in the formation of both
primitive blood (Kallianpur et al., 1994; Robb et al., 1995;
Shivdasani et al., 1995) and definitive HSC (Porcher et al., 1996;
Robb et al., 1996). In zebrafish embryos, forced expression of
scl expands blood and endothelial tissues at the expense of
other mesodermal derivatives (Gering et al., 1998, 2003), and
MO-mediated knockdown of scl expression ablates primitive
hematopoiesis (Dooley et al., 2005; Patterson et al., 2005). Loss
of runx1 and c-myb-expressing cells in the post-circulation
ICM, and rag1-expressing lymphocytes in the thymus, implies
that the knockdown also ablates definitive hematopoiesis
(Dooley et al., 2005), but this could be secondary to the failure
to form the dorsal aorta, from which these cells might be derived
(Patterson et al., 2005).
To use the in vivo imaging and embryonic manipulations that
are possible in zebrafish, but not in mammals, to study blood and
endothelial development, we determined to generate a line of
transgenic zebrafish-expressing GFP in blood and endothelial
precursors. We wished to use in vivo imaging to examine the
behavior of the cells that gives rise to the primitive blood, and, in
particular, to prove that the ICM is generated by medial
migration of PLM cells. Furthermore, we hoped that the line
would enable us to identify the site of initiation of definitive
hematopoiesis. Since scl is clearly a key regulator of primitive
and definitive hematopoiesis, and of vasculogenesis, and is
expressed from the early stages of these processes, we chose to
use the control elements of the scl locus to drive GFP expression
in transgenic zebrafish.
In this paper, we show that embryos transgenic for GFP
under the control of the scl locus accurately recapitulate scl
expression. We use these embryos to prove that the ICM
(erythroblasts and trunk vessel angioblasts) is, indeed, formed
by cells migrating from the PLM. The scl expression domain in
the anterior lateral mesoderm (ALM) similarly gives rise to
both blood cells (in this case macrophages), and angioblasts of
the head vasculature. GFP expression (supported by co-
expression of multiple hematopoietic markers) identifies
clusters of cells between the DA and PCV as being a likely
site of the initiation of definitive hematopoiesis. This
identification is supported by the effects of drug treatment,
and MO-mediated gene knockdown experiments that ablate
definitive hematopoiesis.
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Maintenance and staging of zebrafish
King’s College wild-type zebrafish were maintained and bred as described
inWesterfield (1993). Staging was performed according to Kimmel et al. (1995).
Blood vessel nomenclature follows that of Isogai et al. (2001). To prevent
pigment formation at later embryonic stages, embryos were treated with 0.003%
PTU (1-phenyl-2-thiourea, Sigma) from 12 hpf. Where necessary, embryos were
anesthetized with 0.2 mg/ml MS222 (ethyl 3-aminobenzoate methyl sulfonate,
Sigma), prepared as in Westerfield (1993).
Generation of GFP marked scl loci
Our initial experiments were performed using the Fugu rubripes SCL locus.
A plasmid was kindly provided by Linda Barton (University of Cambridge) that
contained an Xba1-Sal1 fragment comprising 10.4 kb of Fugu genomic
sequence around the SCL gene (FrSCL10.4, in Barton et al., 2001). This
corresponds to bases 16691–27131 of GenBank AJ131019. This had been
modified by using recET-mediated recombination (Muyrers et al., 1999) to
insert GFP at the initiation codon of SCL (Fig. 1D). After failure to obtain
detectable GFP expression in germline transgenics using this construct, we
switched to using the zebrafish scl locus.
A PAC clone that contained 84.5 kb of zebrafish genomic sequence
(GenBank accession number AL592495), cloned in the P1 artificial chromosomeFig. 1. DNA constructs used to generate transgenic zebrafish. (A) The structure of the
polyadenylation signal; and a selectable marker, chloramphenicol acetyl transferase
cassette was PCR amplified using primers that contained 50 bases of homology to seq
the genomic insert in the PAC clone used in this study (GenBank accession number A
flanking genes (ier5 and map17) and the 3′ end of a third (mupp1). Synteny of scl
‘recombineering’ was used to insert the targeting construct into the second exon of
removed by inducing expression of flp recombinase. This modified PAC was used t
subfragment of the scl gene that was amplified from the PAC and used to generate th
upstream of the transcription start site; the conserved non-coding first exon; the first in
The structure of the Fugu rubripes construct used in the initial, unsuccessful, attempt
the SCL locus. It consists of an Xba1-Sal1 fragment containing 10.4 kb of Fugu gen
GenBank AJ131019. This region contains the Fugu SCL gene, a saccular collagen/o
These genes are not syntenic in zebrafish or amniotes. GFP was inserted in place of(PAC) vector, pCYPAC6, was kindly provided by Bertie Gottgens (University of
Cambridge, UK). The scl PAC clone was transformed by electroporation into the
EL250 strain of Escherichia coli. This strain contains a temperature inducible
lambda recombinase operon, and an arabinose inducible flp gene (Lee et al.,
2001). Transformants were selected for kanamycin resistance conferred by the
PAC.
To generate a selectable GFP targeting cassette we modified pCSGFP2
(described in Gering et al. 1998), which contains GFP2 (Zernicka-Goetz et al.,
1996) followed by the SV40 late polyadenylation signal. A chloramphenicol
resistance gene (CAT) flanked by FRT sites was PCR amplified from pKD3
(Datsenko and Wanner, 2000) using the primers CCAAGGGCCCGTGTAGG-
CTGGAGCTGCTTC and CCAACGGCCGACATATGAATATCCTCCTTAG.
The PCR product was cut with Eag1 and Apa1 and inserted downstream of the
SV40 polyadenylation site of Not1/Apa1 cut pCSGFP2. This destroyed the Not1
site, allowing us to release the whole insert from the targeted PAC for injection
into zebrafish (see below).
We then inserted the GFP2-CAT cassette in place of the translation initiation
site of scl in the zebrafish PAC by using lambda recombinase-mediated
recombination in E. coli (Lee et al., 2001). The GFP2-CATcassette (Fig. 1A) was
PCR amplified. The upstream primer, TTACAACTTGATTTGGATAC-
CACTTTGTACATTTTCTGGGATCGCGCCGAACCATGAGTAAAGGA-
GAAGAAC consisted of 50 bases of sequence identical to bases 41052–41102
of AL592495 followed by 22 bases corresponding to the translation initiation site
of GFP2. The downstream primer, CAGCCCTCCGTGCTCGGGCTCAGCG-
GAAATTGCTCGGATTTCAGTTTTTCGTGTAGGCTGGAGCTGCTTC,
consisted of 50 bases reverse–complementary to bases 41111–41160 oftargeting cassette. This consists of the green fluorescent protein GFP2; an SV40
(CAT). The CAT gene is flanked by FRT sites (black triangles). The targeting
uences either side of the first ATG of the zebrafish scl gene. (B) The structure of
L592495). This region contains the zebrafish scl gene, along with two complete
with map17 is also found in amniote SCL loci. Lambda recombinase-mediated
the zebrafish scl gene at the translation initiation site. The CAT gene was then
o generate the first GFP transgenic line. scl-PAC-GFP. (C) The structure of the
e second GFP transgenic line, scl-6kUS-GFP. This contains 6.25 kb of sequence
tron; and GFP2 inserted into the second exon in place of the first ATG of scl. (D)
s to generate germline transgenic zebrafish-expressing GFP under the control of
omic sequence around the SCL gene, corresponding to bases 16691–27131 of
tolin gene, and the 3′ end of an uncharacterized PDZ domain-containing gene.
the initiator ATGs of SCL in exon2.
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of CAT. The template was then destroyed by Dpn1 digestion.
Recombination in E. coli was performed essentially as described in Lee et
al. (2001). Briefly, EL250 cells containing the scl-PAC were grown at 31 °C to
an OD600 of 0.6, and expression of the lambda recombinase operon was
induced by a 15-min heat shock at 42 °C. After chilling on ice, the cells were
electroporated with the linear targeting cassette, and recombinants were
selected by growth on kanamycin+chloramphenicol plates. We found that the
1.5-h post-electroporation incubation prior to plating used by Lee et al. (2001)
was insufficient for the cells to express chloramphenicol resistance. It was
necessary to extend this incubation to 3 h (at 31 °C) or overnight (at room
temperature). Targeting was confirmed by PCR, and the fusion sequences were
sequenced directly on PAC DNA. This showed that targeting was as predicted.
Restriction enzyme footprinting was used to confirm that no gross rearrange-
ments or deletions to the PAC had occurred due to the induction of recombinase
activity. The CAT sequences were removed by arabinose-induced, flp-mediated,
recombination between the flanking FRT sites (Lee et al., 2001), followed by
replica plating on kanamycin and chloramphenicol plates to confirm loss of
chloramphenicol resistance. The loss of the CAT sequence between the FRT
sites was confirmed by direct sequencing, and the integrity of the clones
checked by restriction enzyme footprinting. The final construct, scl-PAC-GFP,
is shown in Fig. 1B.
To generate a construct with the proximal 5′ control sequences of scl driving
GFP2, we performed long-range PCR on the GFP-containing PAC using high-
fidelity KOD polymerase (Novagen) according to the manufacturer’s instruc-
tions. The upstream primer, GGCTCGAGTGACATATCACCGGAATCTC,
primes from 32,833 of AL592495. This is 8272 bp upstream of the first ATG of
scl, and 6247 bp upstream of the transcriptional start site. The downstream
primer, GGTCTAGACACCTTATGGCTGAGTTCTG, primes from 42,427 of
AL592495. This is in exon 2 of scl immediately downstream of the inserted
GFP2 sequence. To allow I-Sce1 stimulated transgenesis (Thermes et al., 2002),
the amplified fragment (Fig. 1C) was cut with Xho1 and Xba1 and cloned
into the vector pBI2, which flanks the insert with recognition sites for
the meganuclease I-Sce1 (Thermes et al., 2002), to generate the plasmid
pBI2-6kUS.
Microinjection and generation of transgenic lines
To generate transgenics, DNA solutions were pressure injected into the
forming cytoplasm of zebrafish embryos at early one-cell stage, using a
Picospritzer II (Parker Hannifin). An eyepiece graticule on a Nikon SMZ-U
microscope was used to measure the size of the injected droplet, which was
adjusted to 2 nl. The concentrations of DNA were titrated to determine the
maximum level that did not cause developmental abnormalities inmore than 10%
of embryos. For the Fugu plasmid and scl-PAC-GFP, the inserts were cut out of
the vectors using Sal1 and Not1 respectively, and diluted in 100 mM KCl for
injection. The Fugu fragment was injected at 100 μg/ml and the scl-PAC-GFP
clone at 20 μg/ml. For I-Sce1-mediated transgenesis, we adapted the method of
Thermes et al. (2002). The composition of the injection mix used for medaka
transgenesis in that study proved unacceptably toxic for zebrafish. After titration
of the components, we obtained satisfactory results using amix containing 10 μg/
ml uncut pBI2-6kUS plasmid, 0.5 U/μl I-Sce1 enzyme (New England Biolabs),
and a 1:50 dilution of ‘10×’ I-Sce1 buffer in 100mMKCl (final concentrations in
injectionmix: 100mMKCl, 50mMNaCl, 2 mMTris–HCl, 2 mMMgCl2, 1 mM
DTT, 1 mM KPO4, 5% glycerol). Embryos were screened for GFP expression at
1–2 dpf, and those showing tissue-specific GFP expression in more than 10 cells
were grown to adulthood. These potential founders were screened for the
transmission of transgenes by breeding to wild-type fish and examination of the
resultant embryos. Because of the possibility of mosaic integration in the
germline, potential founders were only scored as non-transgenic after at least 100
of their offspring had proved negative for GFP expression.
To label the cells of developing embryos with nuclear-localized monomeric
red fluorescent protein (mRFP1, Campbell et al., 2002) we injected the plasmid
pCS-H2B-mRFP1 (Megason and Fraser, 2003), which expresses a fusion protein
of Histone2B to mRFP1, under the control of the simian CMV IE94 promoter. In
order to label only a proportion of cells we injected 0.2 nl of a 50 mg/ml solution
(in 100mMKCl) of supercoiled plasmid, and targeted single blastomeres of 8- to
16-cell embryos.Microscopic observation and time-lapse imaging
Embryos were screened for GFP expression using a Leica MZ-FLIII
fluorescence dissecting scope with an eGFP filter set. For photography using a
compound microscope, living GFP-expressing embryos were anesthetized, and
immobilized against a cover slip using 1% low-melting temperature agarose
(SeaPlaque, BioWhittaker Molecular Applications, ME, USA) in 10% Hanks
buffered saline, confined by a glass ring. DIC and fluorescent mages were
acquired using a Zeiss Axioplan II microscope fitted with a Hamamatsu Orca-
ER digital camera (Hamamatsu Photonics), driven by Improvision software.
Images were exported as TIFFs. Image processing was performed using
PhotoShop CS (Adobe). This processing was confined to gamut adjustment,
minor contrast enhancement, montaging, and false coloring the monochrome
GFP fluorescence images to green. In order to ensure comparability between the
images of the two transgenic lines (shown in Fig. 6), the images were acquired
with the same microscope and camera settings, and macros were recorded using
the ‘Actions’ function of Photoshop to ensure that the image processing was the
same.
For confocal 3D timelapse, it was necessary to adapt the mounting
technique, since mounting in a completely solid medium resulted in distortions
of embryonic morphology by blocking tail outgrowth. We therefore pushed the
tailbud of the embryo into a small drop of 3% methyl cellulose (Sigma)
dissolved in 10% Hanks buffered saline, which had been placed on a cover slip,
then covered this with 1% low-melting temperature agarose. 5D timelapse
imaging was performed on a Nikon C1 microscope with a 20× water
immersion objective. The confocal images were exported as TIFFs and
imported into ImageJ (http://rsb.info.nih.gov/ij/) for analysis. In the embryos
scatter labeled with H2B-mRFP1, the RFP-labeled nuclei of GFP-expressing
cells were identified by processing the 5D datasets to identify pixels where red
and green fluorescence were both present, using the ImageJ plugin ‘RG2B
colocalization’. The paths of these nuclei were then manually tracked in 3D
through time using the plugin ‘manual tracking 2zt’ (Figs. 3A–D;
Supplementary movie 2) or the plugin ‘MTrackJ’ (http://www.imagescience.
org/meijering/software/mtrackj/) developed by Eric Meijering (Figs. 3E–H;
Supplementary movie 4).
Embryo staining
Staining for hemoglobin using diaminofluorene (DAF) was performed as
described by Weinstein et al. (1996). Whole-mount in situ hybridization was
performed as in Gering et al. (1998). The color signal was developed with
either BM Purple (Roche Diagnostics) for Fig. 5, or Fast Red (Sigma) for
Supplementary Fig. 2.
Dioxin treatment and antisense morpholino injections
To ablate definitive hematopoiesis, we used two different methods. Firstly,
embryos were treated with the dioxin TCDD (2,3,7,8-tetrachlodibenzo-p-dioxin)
(Belair et al., 2001). Embryos were exposed to 6 ng/ml TCDD in 10% Hanks
buffered saline for 1 h at 12 hpf. Control embryos were exposed to vehicle (0.1%
DMSO) alone. Secondly embryos were injected at 1- to 4-cell stages with a 2 ng
of an antisense morpholino oligonucleotide (GeneTools llc., Philomath OR,
USA) targeted to the second exon splice donor site of zebrafish runx1 (Gering
and Patient, 2005). This morpholino (sequence 5′-AGCGCTCTTACCG-
TATTTGGCGTCC-3′) was kindly provided by Martin Gering (University of
Nottingham, UK).Results
Generation of transgenic zebrafish-expressing GFP under the
control of the scl locus
The expression of the mouse SCL gene is under the control
of at least five enhancers, and these lie both 5′ (Sinclair et al.,
1999), 3′ (Sanchez et al., 1999; Delabesse et al., 2005) and
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gene. We therefore reasoned that in order to fully recapitulate
the expression of scl in a GFP transgenic zebrafish line, we
should use as much of the locus as possible. Transient in-
jections of a 10.4-kb genomic clone containing the SCL gene
of the pufferfish Fugu rubripes into zebrafish embryos had
showed mosaic, but tissue-specific, expression of the Fugu
SCL message (Barton et al., 2001). We therefore injected a
modified version of this construct, in which the eGFP coding
sequence was inserted into the first coding exon of Fugu SCL
(Fig. 1D), into fertilized zebrafish eggs. In injected embryos,
transient GFP expression was seen specifically in sites of
endogenous scl expression. However, expression of GFP was
highly mosaic: typically, fluorescence was only detectible in
fewer than 20 cells per embryo. We grew over 400 potential
founders to adulthood, but were unable to detect any GFP
expression in their offspring.
We therefore switched to the zebrafish scl locus. A PAC
clone with an 84.5-kb zebrafish genomic DNA insert,
containing the scl gene had been characterized by our
collaborators (Gottgens et al., 2002). This region contains
the scl transcription unit, an upstream gene, ier5, one
complete downstream gene, map17, and part of a second,
mupp1 (Fig. 1B). Only map17 is syntenic in mammals (but
not in Fugu) implying that the control regions for zebrafish
scl may all be contained in this clone. Sequence comparisons
of the zebrafish scl locus with mammalian and Fugu SCL
genes identified conserved sequences in the proximal
promoter, the first (non-coding) exon and in the 3′untranslated
region. However, it seemed unlikely that the control elements
of zebrafish scl would be confined to these regions, since the
comparisons performed did not identify known functional
enhancers in mouse (Gottgens et al., 2002). We therefore
decided to generate transgenic zebrafish using the whole of
this PAC clone. We used ‘recombineering’ (Lee et al., 2001)
to insert GFP2 (Zernicka-Goetz et al., 1996) into the first
coding exon of scl to generate the construct scl-PAC-GFP
(Figs. 1A, B).
Injection of scl-PAC-GFP into zebrafish embryos resulted in
much more widespread GFP expression than in those injected
with the Fugu plasmid (Supplementary Fig. 1). This was
despite a 40-fold lower molar amount of the zebrafish scl-PAC-
GFP construct being injected. This implies that, although the
Fugu SCL-GFP construct contains the elements required for
tissue-specific expression, promoter activity in zebrafish is poor
so that GFP can only be detected in a few cells in transient
injections, and none at all in germline transgenics. Expression
of GFP from zebrafish scl-PAC-GFP was confined to the
endogenous expression domain of scl. We grew fish showing
expression of GFP in more than 20 cells to adulthood and tested
for transmission of GFP expression to their offspring. After
testing 125 potential founders, we found a fish that transmitted
GFP expression to 1.5% of his offspring, indicating a mosaic
germline due to a late integration event. In subsequent
generations, GFP expression was transmitted in Mendelian
fashion, to 50% of the offspring of carriers, indicating a single
integration site.Expression of GFP in fish transgenic for zebrafish
scl-PAC-GFP recapitulates that of endogenous scl
The expression of GFP in the zebrafish scl-PAC-GFP trans-
genic line appears to fully recapitulate that of the endogenous
scl gene (Fig. 2). This was confirmed by probing transgenic
embryos for both endogenous scl message, and GFP protein
(Supplementary Fig. 2). GFP fluorescence is first detectable at
5–6 somites (12 h post fertilization, hpf), in the anterior part of
the posterior lateral mesoderm (PLM). Expression of scl
mRNA can be detected by in situ hybridization from around an
hour earlier (2 somites, Gering et al., 1998). This delay in
fluorescence detection is likely to result from the time
necessary for synthesis and maturation of the GFP protein.
GFP expression spreads caudally to comprise the entire length
of the PLM (Fig. 2A). Shortly after its appearance in the PLM,
GFP begins to be expressed in the anterior lateral mesoderm
(ALM), and in later embryos comprises yolk sac macrophages
and the forming vasculature of the head and the endocardium
(Fig. 2B). Expression of GFP is maintained in the endocardium
throughout embryonic development (Fig. 2E and data not
shown). The expression of endogenous scl mRNA, as detected
by in situ hybridization, moves from the PLM, ventrally to the
somites, and comes to lie in the midline of the embryo (Gering
et al., 1998). Similarly, the PLM stripes of GFP expression
converge to the midline (Fig. 2C) and come to comprise the
intermediate cell mass (ICM: Fig. 2D). The ICM gives rise to
the major axial vessels of the trunk, the dorsal aorta (DA) and
posterior cardinal vein (PCV), along with the differentiating
primitive blood that lies between them. By 24 hpf, GFP can
clearly be seen in the endothelium of other vessels, for example
the mid-cerebellar vessel (Fig. 2E) and the segmental vessels
(Se) of the trunk (Fig. 2F) that sprout from the DA. We had not
previously detected scl message in endothelial cells by in situ
hybridization. We believe, however, that this is authentic
expression in EC, rather than just carry-over of GFP protein
from their precursors, because this endothelial expression is
maintained as late as we have looked (11 days: Fig. 2H).
Furthermore, in mice, endothelial expression of SCL message
could not be detected by in situ hybridization (Green et al.,
1992), but expression could be detected by both antibody
staining for the SCL protein (Kallianpur et al., 1994), and in
transgenic lines in which β-gal had been inserted into the SCL
locus (Elefanty et al., 1999).
As with the endogenous scl gene (Gering et al., 1998;
Sinclair et al., 1999), expression of GFP is also seen in the CNS.
This expression includes ventral interneurons in the spinal cord
and hindbrain, and parts of the midbrain and diencephalon (Fig.
2G). The neural expression of the scl-PAC-GFP construct will
be described in detail elsewhere.
Even after the primitive erythrocytes have entered circula-
tion (beginning at 26 hpf), GFP expression is still seen in the
ICM region (Fig. 2G, arrow). While some of this GFP
expression is in the endothelium of the DA and PCV (Fig. 4),
part of this expression labels the first site of definitive
hematopoiesis (see below). From around 5 dpf, GFP-expres-
sing cells can be detected in the pronephros, the eventual site
Fig. 2. Expression of GFP in the scl-PAC-GFP line completely recapitulates that of endogenous scl (see also Supplementary Fig. 2, online) The figures are composites
of DIC and fluorescence images. Except where stated otherwise, all figures are lateral views with anterior to the left. (A) 11 Somites (14.5 hpf), dorsal view of trunk,
anterior to left. GFP is expressed in the blood and endothelial precursors in the posterior lateral plate mesoderm (PLM). (B) 14 Somites (16 hpf), dorsal view of head,
anterior to left. GFP is expressed in primitive macrophages (arrow) migrating out onto the yolk cell, and the precursors of the head vasculature, including the
endocardium (arrowhead). (C) 16 Somites (17 hpf), dorsal view of trunk, anterior to left. GFP expression converges, under the somites, towards the midline. (D) 18
Somites (18 hpf). The GFP-expressing cells in the trunk have formed the intermediate cell mass (ICM, arrow) ventral to the notochord. (E) 24 hpf. As well as the ICM,
GFP is expressed in the developing vasculature including the mid cerebellar vessel (arrowhead) and the endocardium and aortic arches. (F) 24 hpf, higher
magnification of the trunk. GFP is expressed in the differentiating erythroid cells in the ICM (large arrow) and the endothelium of the segmental vessels (small arrows)
that sprout from the dorsal aorta. (G) 48 hpf. GFP is expressed in the CNS, with particularly strong expression in the midbrain (arrowhead) and part of the
diencephalon, and in interneurons in the ventral hindbrain and spinal cord. Expression is also visible in the ICM after the primitive erythroid cells have entered
circulation (arrow). The fluorescence in the region of the yolk cell results from the flow of blood returning to the heart over the anterior surface of the yolk, along with
autofluorescence of the yolk granules. (H) 11 dpf. GFP expression in the CNS and ICM is maintained at the latest stage we have examined in detail. Autofluorescence
is also seen in the gut. (I) 11 dpf, high magnification view of the pronephric region. Round GFP-expressing cells are visible in this region, the site of hematopoiesis
through adulthood. The diffuse fluorescence in the lower half of the micrograph is autofluorescence in the gut.
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we have looked (11 dfp: Fig. 2I).
Cells migrate medially from the PLM to form the ICM
We and others have previously shown that the expression of
blood and hematopoietic markers moves from the PLM to the
midline ICM during late somitogenesis stages (Brown et al.,
2000; Detrich et al., 1995; Fouquet et al., 1997; Gering et al.,
1998). We therefore wanted to prove that this movement of gene
expression did indeed result from themovement of the blood and
endothelial precursors. We performed timelapse experiments on
the scl-GFP PAC transgenics, and these experiments showed
movement of GFP expression from the PLM to ICM. However,
because the GFP-expressing tissue passes deep to the somites,
and becomes very flat, it proved impossible to distinguish
individual cells during this movement.We therefore developed atechnique to track single cells during this movement. Briefly,
cells within a transgenic embryo were scatter labeled with a
nuclear localized monomeric red fluorescent protein (Histo-
ne2B-mRFP fusion protein), by injecting an expression plasmid
at 8- to 16-cell stages. Two-color confocal timelapse was
performed on these embryos. Fig. 3A shows a 2D projection of a
dorsal view of the trunk of one such embryo at 11 somites (dotted
line indicates embryonic midline), and Fig. 3B the same embryo
at the end of a 3-h timelapse (approximately 16 somites). We
then processed the 5D dataset (see Materials and methods) to
identify colocalization of red and green fluorescence. This
allowed us to identify only those red nuclei that were in GFP-
expressing cells: Fig. 3C shows the position these nuclei at the
start of the timelapse. We then tracked the movement of the
nuclei in 3D during the timelapse. Fig. 3D shows the final
position of these nuclei and the tracks followed by a selection of
them (see Supplemental movies 1 and 2). These experiments
Fig. 3. Migration of blood and endothelial precursors. Projections of confocal images from timelapse experiments performed on scl-PAC-GFP transgenic embryos
scatter labeled with nuclear-localized H2B-mRFP1 fusion. (A–D) Migration of blood and endothelial precursors from the PLM to the trunk midline. Dorsal view of
trunk, anterior to top, dotted line indicates embryonic midline. 3-h Timelapse, 12-min intervals. (A) Projection of GFP and RFP expression at the start of the timelapse
(11 somites, 14.5 hpf). The GFP cells are in the PLM. (B) Projection of GFP and RFP expression at the end of the 3-h timelapse (16 somites). GFP expression has
begun to reach the midline in the anterior part of the trunk. (C) Colocalization of GFP and RFP expression identifies the nuclei of a subset of the GFP-expressing cells.
(Image processed using the ‘RG2B colocalization’ plug-in for ImageJ). (D) The positions of these nuclei at the end of the timelapse are shown, along with the paths
they took during their migration. Several of the cells have reached the midline. It is generally the case that the more rostral cells migrate first. However, the migration of
the cells is not completely synchronous, and the paths of some nuclei cross. For example, the most rostral cell tracked (orange path) migrates later than cells
immediately posterior to it, and crosses their paths. This implies that the cells are migrating independently rather than moving as a tissue en masse. (E–H) Migration of
cells from the ALM domain of scl expression to form the head vasculature and yolk sac macrophages. Dorso-lateral view of head, anterior to the right. 460-min
timelapse, 10-min intervals. (E) Projection of GFP and RFP expression at the start of the timelapse (13 somites, 15.5 hpf). The GFP-expressing domain is lateral to the
midbrain and ventral to the mid- and hindbrain. (F) Projection of GFP and RFP expression at the end of the timelapse (approximately 20 somites). Cells were identified
as macrophages or angioblasts by position, shape and arrangement relative to other cells. The ventral GFP-expressing cells are primitive macrophages that have
migrated out onto the yolk sac, while the remainder are forming the head vasculature. (G) Colocalization of GFP and nuclear RFP at the start of the timelapse. Selected
nuclei are indicated. Those that gave rise to angioblasts are labeled in shades of blue, and those that gave rise to macrophages are labeled in shades of red. (H) Positions
of these nuclei at the end of the timelapse, together with the paths they followed. In this experiment, angioblasts were found in the positions of the lateral aorta (1:7, 1:9,
1:10), primordial hindbrain channel (1:17), primordial midbrain channel (1:13) and optic vein (1:1). The paths taken by five cells that gave rise to macrophages are also
shown. In general, more posterior and medial cells gave rise to angioblasts while more anterior and lateral cells formed macrophages. However, occasional antero-
lateral cells become angioblasts (e.g., 1:1) and some macrophages emerge from more medial positions (e.g., 2.4).
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migrate from the PLM to form the ICM. Furthermore, we did not
see any de novo expression of GFP appearing in the midline of
transgenic embryos, implying that the trunk vessels and
primitive blood are likely to be entirely derived from the PLM.The movement of PLM cells showed a general anterior to
posterior wave of migration initiation. Thus, the more rostral
cells generally reached the midline while cells that were more
caudal were still migrating or had not yet initiated migration
(Fig. 3D). However, the movement of cells at a given antero-
Fig. 4. The development of hematopoietic clusters during late embryogenesis.
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migration tracks showed some crossing. This implies that the
movement consists of individual migration of cells rather than
the en masse movement of a cell sheet. There is evidence that
the scl-expressing cells in the PLM are heterogeneous for the
expression of some other blood and endothelium-expressed
genes even prior to the initiation of migration (Dooley et al.
2005, and our unpublished data). This may account for the
heterogeneous behavior of these cells during migration. To our
knowledge, this is the first time that the migration of blood and
endothelial precursors has been imaged at the single-cell level in
the living vertebrate embryo.Cells migrate from the ALM to form head vasculature and
primitive macrophages
The anterior domain of scl expression is in the ALM, lateral
and ventral to the mid- and hindbrain. We performed timelapse
experiments, similar to those performed on the PLM, to image
the migration and fate of these cells. Fig. 3E shows a dorso-
lateral view of the head of a 13-somite transgenic embryo
scatter labeled with H2B-mRFP1. Fig. 3F shows the samePanels A–J show paired lateral views (left panel DIC, right panel GFP
fluorescence) in scl-PAC-GFP transgenic embryos. Panels A, C, E, G and I show
mid-trunk, and B, D, F, H and J show the ventral tail. Panel K shows paired views
of the mid-trunk of a 4 dpf fli1-promoter-GFP transgenic embryo. Panel L andM
show DAF staining for globin expression in the trunk and tail, respectively, of a
4 dpf embryo. Red bars indicate the dorso-ventral positions and sizes of the
lumens of the major artery (DA in trunk, CA in tail). Blue bars indicate the
lumens of the major vein(s) (PCV in trunk, CV in tail). All images are centred on
boundaries between somites in the adjacent paraxial mesoderm. (A) Soon after
the primitive erythroid cells of the ICMhave entered circulation (31 hpf), the floor
of the DA and roof of the PCV are closely apposed, and consist of thickened
endothelia. These endothelia express GFP (A′) as do the circulating erythroid
cells (blurred fluorescence in the lumens of the vessels). (B) The ventral tail
region contains the CA and the anastomosing vessels comprising the CV. GFP
(B′) is expressed in these endothelia and in clusters of round cells interspersed
among the venous network. (C) 2 dpf: the endothelia of the floor of the DA and
roof of the PCV have thinned and occasional cells with a rounder morphology
are visible between the endothelia. These express GFP (C′). (D) Multiple round
cells expressing GFP (D′) are present between the CA and CV. (E) 3 dpf: the DA
and PCV have separated. Occasional round GFP-expressing cells adhere to the
ventral surface of the DA (small arrows), but the majority of such cells have
started to form small clusters on the roof of the PCV (large arrows). These
clusters are adjacent to the boundaries between somites. (F) GFP-expressing
round cells occupy much of the tissue between the CA and PCV. (G) 4 dpf: the
GFP-expressing clusters have expanded in size (typically 5–25 cells), and the
ventral-most cells are in contact with the lumen of the PCV (see also panel I). (H)
More of the GFP-expressing round cells are present ventrally (near the CV) than
dorsally (near the CA). (I) 6 dpf: the trunk clusters have begun to reduce in size.
Ventral cells project into the lumen of the PCV and are presumably entering
circulation. Small cluster are seen as late as 11 dpf (data not shown). (J) The
hematopoietic cells in the tail are all associated with the roof of the CV. This
expression is also maintained through later embryonic development. (K)
Expression of GFP under control of an endothelium-specific fli1 promoter labels
cells surrounding the trunk clusters, but not the cells in the clusters themselves.
This GFP-expressing endothelium appears continuous with that of the PCV.
Note, this does not imply that the clusters do not express endogenous fli1, only
that the endothelial-specific promoter contained in the fli1-GFP construct is not
active in these cells. (L) 4 dpf, trunk: a subset of cells in the trunk clusters
expresses globin, as visualized by DAF staining. Staining can also be seen in
circulating erythrocytes, both in the DA (dorsally) and PCV (ventrally). (M)
Similarly, some of the cells between the CA and CV also express globin. (N)
Lateral view of a 3 dpf embryo (bright field). The size and positions of the
micrographs labeled ‘trunk’ and ‘tail’ in this image and in Figs. 5 and 6 are
indicated. (O) ‘Virtual transverse section’ through the trunk of a living scl-PAC-
GFP transgenic embryo, reconstructed from a confocal stack. GFP fluorescence
in green, autofluorescence (predominantly pigment cells on the embryo surface)
in blue. The hematopoietic clusters are in the midline of the embryo, between the
paired hypaxial somites. (P) Schematic to aid interpretation of the DIC and
fluorescence images in this image and in Figs. 6 and 7. A DIC image of the trunk
region of a 4 dpf embryo has been false-colored to indicate the most important
features: hematopoietic cluster—green; dorsal aorta—red; PCV—purple;
somite boundary—yellow. At this stage of development, the cluster lies adjacent
to the somite boundary, and in contact with the roof of the PCV. There is an out-
pocketing of the PCV at the site of the cluster.
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movie 3). The paths of the nuclei of GFP-expressing cells were
tracked, and their paths are shown in Figs. 3G and H (and see
Supplementary movie 4). At the end of the timelapse, the GFP-
expressing cells were found to have two fates. This identifica-
tion was based on their position, cell shape and arrangement
relative to other GFP-expressing cells. They formed either
primitive macrophages (on yolk sac; amoeboid; usually isolated
cells) or angioblasts (in the sites of formation of head vascu-
lature; extended cytoplasm; in contact with other cells with the
same phenotype). We confirmed that cells tentatively identified
as angioblasts did indeed form the head vessels in timelapses
extended to later stages (Supplementary movie 5). There was a
tendency for cells in more posterior and medial regions of the
initial expression domain to become angioblasts, and for those
more anterior and lateral to become macrophages. However,
some anterior cells became angioblasts in the region of the eye
and forebrain, while occasional macrophages emerged from the
medial part of the initial expression domain.
Initiation of definitive hematopoiesis
Because, in amniotes, definitive HSCs are thought to arise in
AGM region of the trunk and since we could detect expression
of GFP in the anatomically homologous region of scl-PAC-GFP
transgenic zebrafish after the primitive blood had entered
circulation (Fig. 2G), we investigated this expression further
(Fig. 4).
Prior to the entry into circulation of the primitive erythro-
blasts of the ICM, the DA and PCVare separated by these cells.
Once the primitive erythroid cells have entered circulation (26–Fig. 5. Expression of hematopoietic markers in the trunk clusters and ventral tail of
(purple) of scl (A); runx1 (B); lmo2 (C); c-myb (D); gata1 (E); and βE1 globin (F). T
Compared with the other markers runx1 expression is expressed in much fewer cell30 hpf), the floor of DA and the roof of the PCV become closely
apposed. The endothelial cells express GFP in the scl-PAC-GFP
transgenics (Fig. 4A′). By differential interference microscopy
of live embryos, it appears that, while the endothelial cells are
thicker in the ventral wall of the DA and the dorsal wall of the
PCV, the two endothelia are in direct contact (Fig. 4A). By 2 dpf
(Fig. 4C), the DA and PCV begin to separate, and occasional
GFP-expressing cells with a rounder morphology can be
detected between the two endothelia (Fig. 4C′). At 3dfp (Fig.
4C), the DA and PCV have separated considerably (Fig. 4E).
Most (Fig. 4E′, large arrow) but not all (Fig. 4E′, small arrow) of
the round GFP-expressing cells are now associated with the roof
of the PCV, and form clusters of cells with the characteristic
round morphology of hematopoietic cells (Fig. 4E). At 4 dpf, the
round GFP-expressing cells form clusters typically consisting of
5–25 cells on the roof of the PCV (Fig. 4G′), with some cells
(presumably those about to enter circulation) projecting into the
lumen of the vein (Fig. 4G). The clusters are surrounded by
endothelial cells (visualized by GFP expression in a Fli1
promoter-GFP transgenic line (Lawson and Weinstein, 2002)),
and these endothelial cells appear to be continuous with the
endothelium of the PCV (Fig. 4K).
The size of the clusters varies along the length of the trunk.
This variation in cell numbers does not appear to correlate with
the antero-posterior position of the cluster. Interestingly, the
positions of the clusters coincide with the somite boundaries,
possibly implying a response to a signal from the neighboring
somitic mesoderm. By 6 dpf, the clusters are generally smaller
(Fig. 4I), implying that many of the cells have entered the
circulation. This may also reflect a shift of the major site of
hematopoiesis to the pronephric kidney (Al-Adhami and Kunz,4 dpf embryos. Whole-mount in situ hybridization to show mRNA expression
his expression supports the identification of the trunk clusters as hematopoietic.
s in the ventral tail.
Fig. 6. Treatments to block definitive hematopoiesis ablate the trunk
hematopoietic clusters, but have less affect upon tail hematopoiesis. Panels
show paired DIC and GFP fluorescence images of 4 dpf scl-PAC-GFP
transgenic embryos. The lumens of the major vessels are indicated as in Fig. 4.
Panels A, C, and E are lateral views in the mid-trunk, centred on a somite
boundary. Panels B, D, and E show the ventral tail. Panels A and B show a
control embryo from a TCDD experiment, treated with vehicle (0.1% DMSO)
alone. Panels C and D are an embryo treated with 6 ng/ml TCDD at 12 hpf.
Panels E and F are an embryo injected with 2 ng of a splice-blocking antisense
morpholino oligonucleotide (MO) targeted to runx1. (A) A typical trunk
hematopoietic cluster consisting of approximately 15 GFP-expressing round
cells. Interestingly, this cluster is associated with one of the transient vessels that
link the DA and PCVat this time (Isogai et al., 2001). This is the case for some,
but not all, of the hematopoietic clusters at this stage. (B) The tail contains many
hematopoietic cells, predominantly associated with the roof of the CV. (C) In
embryos treated with TCDD, the formation of trunk hematopoietic clusters is
ablated. In this embryo, only one GFP-expressing cell with round morphology
was seen (arrow). All other GFP-expressing cells between the DA and PCV have
disorganized endothelial morphology. (D) In the tail of TCDD-treated embryos
there is a slight increase in GFP-expressing cells having endothelial morphology
and a slight decrease in cells with hematopoietic morphology. However,
plentiful hematopoietic cells are still detectable. (E) In runx1 MO-injected
embryos, trunk hematopoietic clusters are completely ablated. Endothelial cell
morphology was normal, but, interestingly, the separation of DA and PCV is
reduced. (F) In the tail of runx1 MO-injected embryos, the number of GFP-
expressing hematopoietic cells is marginally reduced. Endothelial morphology
is apparently unaffected.
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be detected on the roof of the PCV as late as 11 dpf (the latest
stage we have examined).
The DA becomes the caudal artery (CA) in the tail, and the
blood returns to the PCV via the anastomosing network of the
caudal vein (CV) (Isogai et al., 2001). The tissue between these
vessels is anatomically continuous with that lying between the
DA and PCV. However, its development appears different to the
trunk. Even after the primitive erythroblasts of the trunk have
entered circulation, clusters of cells with round morphology that
express GFP are present between the CA and CV (Figs. 4B and
B′). This GFP-expressing population expands to occupy much
of the tissue between the CA and CV (Figs. 4D, F and H), with
the round cells mingled among the braided vessels of the
vascular network of the tail. From 4 dpf, the vascular network of
the tail becomes less branched and most of the returning
circulation travels through one or two CVs (Isogai et al., 2001).
As this occurs, the round, GFP-expressing presumptive hema-
topoietic cells become increasingly localized to the roof of the
CV (Figs. 4H and J). Unlike the clusters in the trunk, these cells
are not confined to the region of the somite boundaries.
The position (in the anatomically homologous position to the
amniote AGM), and timing of emergence (2–3 dpf), of the trunk
GFP-expressing clusters implied that we might have identified
the site of initiation of definitive hematopoiesis. We therefore
tested this hypothesis. To confirm that these clusters were indeed
hematopoietic, we used diaminofluorene (DAF) to stain for the
presence of globin. This showed that some of the cells in the
trunk clusters were differentiating into erythroid cells, confirm-
ing the hematopoietic identity of the clusters (Fig. 4L). Globin-
expressing cells were also detectable in the tissue between the
CA and CV in the tail (Fig. 4M). We also performed in situ
hybridization to detect expression of a panel of hematopoietic
markers (Fig. 5). At 4 dpf, the trunk clusters express scl (also
further confirming that the expression of GFP reflects the
endogenous expression of the scl gene), lmo2, runx1, c-myb,
and the erythroid markers gata1 and βE1 globin. Ikaros, which
is expressed in the ICM at 2 dpf (Willett et al., 2001), is
undetectable in this region at 4 dpf, despite a clear signal being
present in the thymus (data not shown). All of the markers
expressed in the trunk clusters were also expressed in the ventral
tail. Interestingly, runx1-expressing cells in the tail (Fig. 5B)
were much more sparse than those expressing the other markers.
In order to determine whether the trunk clusters were
definitive or primitive hematopoietic cells, we used two different
treatments to inhibit definitive hematopoiesis. Firstly, treatment
with the dioxin TCDD has been shown to prevent the switch to
‘adult’ erythrocyte morphology that occurs in zebrafish from
4 dpf, without affecting primitive erythropoiesis, and is therefore
thought to specifically inhibit definitive hematopoiesis (Belair et
al., 2001). Treatment with TCDD prevented the formation of the
trunk hematopoietic clusters, with only occasional GFP-
expressing round cells being detectable (compare Figs. 6A and
C). Secondly, Runx1 (AML-1) knockout mice specifically lack
definitive hematopoiesis. Injection of an MO targeted to the
ATG of runx1 has been described as having effects on embryonic
hematopoiesis and vasculogenesis (Kalev-Zylinska et al., 2002).In that study, however, injected fish were clearly deformed and
appeared to have cell death in areas where runx1 is not normally
expressed. This implied non-specific effects of this MO, thus
complicating interpretation of these experiments. More recently
a different, splice-blocking, MO for runx1 has been used
(Gering and Patient, 2005), and shown to result in the loss of c-
myb and ikaros expression in the floor of the dorsal aorta and
reduction or loss of lymphocytes in the thymus. We therefore
used this MO. Injection of the splice-blocking runx1MOdid not
have any noticeable effects on embryonic morphology or excess
cell death, but caused a progressive anemia (detectable by DAF
staining) from 7 dpf (data not shown). This, together with the
data of Gering and Patient (2005), indicates that runx1 is
necessary for definitive hematopoiesis in zebrafish. Embryos
injected with runx1 MO completely lack trunk hematopoietic
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6C). Interestingly, both TCDD treatment and runx1 MO
injection had little effect on the numbers of GFP-expressing
cells in the ventral tail (Figs. 6B, D, and F). This correlates with
the sparse expression of runx1 message in this region (Fig. 6B),
and implies that the majority of these cells may be of the
primitive lineage. Taken together, these data indicate that the
GFP-expressing clusters we have identified in the trunk of
zebrafish represent the initial site of definitive hematopoiesis.
A second scl-GFP line lacking expression in definitive
hematopoiesis
Comparison between zebrafish and other vertebrate SCL loci
detected only three regions of significant sequence homology:Fig. 7. The second GFP transgenic line, scl-6kUS-GFP lacks elements necessary
for expression in definitive hematopoietic clusters. (A) 34 hpf scl-PAC-GFP
embryo, and (B) 34 hpf scl-6kUS-GFP embryo, lateral views. In both embryos,
GFP is expressed in the CNS and endothelium in identical patterns. In panel A,
expression in the primitive erythrocytes is easily seen as they pass over the yolk
cell and enter the heart (arrowhead). In panel B, there is much reduced expres-
sion in erythroid cells, but is still faintly visible (see also, panel F). (C and D)
4 dfp scl-PAC-GFP embryo, mid-trunk hematopoietic cluster. A typical cluster
of approximately 15 cells is visible in the DIC image (C). Strong expression
of GFP in these cells is clearly visible (overlay of fluorescent and DIC image) (E
and F), 4 dfp scl-6kUS-GFP embryo, mid-trunk hematopoietic cluster. A cluster
of approximately 13 cells is visible in the DIC image (E). No expression of GFP
is visible in the cluster (overlay of fluorescent and DIC image). Faint expression
in circulating primitive erythrocytes is visible in the lumen of the vessels.the proximal promoter, the first (non-coding) exon and the 3′
UTR (Gottgens et al., 2002). The murine SCL locus has more
distant enhancers both 5′ (Sinclair et al., 1999), and 3′ (Sanchez
et al., 1999; Delabesse et al., 2005). However, no sequences
related to these enhancers were detectible in the zebrafish locus.
We therefore reasoned that we might be able to recapitulate at
least some of the expression of zebrafish scl using a construct
containing only the proximal promoter and first non-coding
exon. We therefore PCR-amplified a 10-kb fragment from the
GFP-modified zebrafish scl PAC. This contained 6.25 kb of
upstream sequence, the first exon, first intron, and GFP inserted
into the second exon (Fig. 1C). We used I-Sce1-mediated
integration (Thermes et al., 2002) to generate a second trans-
genic line, ‘scl-6kUS-GFP’.
This line fully recapitulated the expression in the CNS and
endothelium seen with the whole PAC (Figs. 7A and B). Levels
of expression comparable to those of the scl-PAC-GFP construct
were also seen in the PLM (data not shown), however, ex-
pression fell in the cells that differentiated into erythroblasts.
GFP expression in circulating primitive erythrocytes was lower
in scl-6kUS-GFP transgenics (Figs. 7A and B arrowheads),
whereas expression in endothelial cells was maintained.
Most strikingly, expression of GFP in the definitive
hematopoietic clusters in the trunk (Figs. 7E and F) was
completely absent in the scl-6kUS-GFP line. This indicates that
an enhancer (or enhancers) required for expression in definitive
hematopoietic cells is absent in this construct. We are currently
attempting to identify these sequences. These two lines will
provide a powerful tool to identify genes expressed specifically
in the definitive hematopoietic clusters, by using FACS-sorted
GFP-expressing cells from the two lines as sources of cDNA for
subtractive hybridization and gene chip assays.
Discussion
A sting in the “tale of two fishes”
We initially attempted to generate transgenic zebrafish-
expressing GFP under the control of the Fugu rubripes SCL
locus. This was because analysis of this locus had indicated that,
in commonwith many genes in this organism, the SCL locus was
highly ‘compressed’ relative to that of other vertebrates (Barton
et al., 2001). Furthermore, lack of synteny of the flanking genes
implied that the regulatory elements of Fugu SCL were likely to
lie within a comparatively short genomic region. We found that
10.4-kb Fugu construct could drive transient tissue-specific
GFP expression when injected into zebrafish embryos. How-
ever, only a few cells were detectably labeled, and none of these
fish was able to transmit detectable GFP expression to their
offspring.
In contrast, when we modified an 84.5-kb PAC clone
containing the zebrafish scl gene we detected much more
widespread, tissue-specific, expression of GFP in injected
embryos, and were able to identify a fish that transmitted
detectable GFP expression to its offspring. This strongly implies
that, although elements responsible for the tissue specificity of
SCL expression are conserved from Fugu to zebrafish, the
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level expression has been lost.
This raises an important caveat to the use of Fugu (and other
tetraodontid) sequences for transgenic analysis in heterologous
organisms. The compacted nature of these genomes makes them
attractive models for searches for regulatory elements (Muller
et al., 2002), but there have only been a limited number of studies
in which correct regulation of these genes has been shown in
animals of different species (for example, rat (Venkatesh et al.,
1997), mouse (Brenner et al., 2002), or Xenopus (Stapleton
et al., 2004)). It may be, therefore, that the divergence of
regulatory sequences is such that, in most cases, it will be more
fruitful to use the endogenous gene. The use of ‘recombineering’
techniques, as used in this study, to modify the larger genomic
loci of model organisms will provide a powerful tool for such
studies.
In vivo imaging of hematopoietic development and
identification of the initial site of definitive hematopoiesis
The scl-PAC-GFP transgenic fully recapitulates endogenous
scl expression. This enabled us to perform, with single-cell
resolution, in vivo timelapse imaging of blood and endothelial
precursor migration. We show that the ICM (which gives rise to
primitive erythroblasts and the trunk vasculature) is formed by
medial migration of cells from the PLM. The movements of
individual cells are not synchronous and crossing of paths can be
observed. This implies that the cells are migrating individually
rather than moving as a coordinated cell sheet. While this
asynchronous movement may be stochastic, it might also
indicate that, within the GFP-expressing PLM domain, cells
have already begun to adopt different fates and express different
migratory behaviors. This is consistent with the fact that the scl-
expressing population in the PLM is heterogeneous for the
expression of some other blood and endothelial markers, even
prior to migration (Dooley et al., 2005, and our unpublished
results). We (Brown et al., 2000), and others (Fouquet et al.,
1997), have shown that there appear to be two waves of
movement of vascular gene expression to the trunk midline. The
first corresponds to the formation of the DA, and the second to
the PCV. Furthermore, medial migration of DA precursors is
inhibited by ubiquitous expression of the guidance molecule
Sema3a1, while the movement of blood precursors appears
unaffected (Shoji et al., 2003). The GFP-expressing PLM
domain may therefore already contain cells with different fates
and responses to guidance molecules. We intend to test this by
single-cell labeling, coupled with imaging of migration and fate.
In vivo timelapse has also allowed us to show that the head
vasculature and primitive macrophages are derived from the
anterior domain of scl expression, and to track the migration of
these cells. The macrophages are predominantly derived from
the anterior/lateral part of the domain, while angioblasts come
mainly from the posterior/medial part. However, some forebrain
angioblasts emerge from the anterior part of the domain, and
some macrophages come from more medial regions, indicating
that there is not a strict spatial division of fates within the scl-
expressing domain.Current evidence in amniotes implies that their definitive
hematopoietic stem cells (HSC) are generated in the aorta–
gonad–mesonephros (AGM) region (reviewed in Godin and
Cumano, 2002). It seemed likely that the anatomically homo-
logous region might be the site of initiation of definitive
hematopoiesis in zebrafish. After the primitive erythroblasts
have entered circulation, several transcription factors implicated
in definitive hematopoiesis are expressed in the ICM (Burns
et al., 2002; Gering and Patient, 2005; Kalev-Zylinska et al.,
2002; Thompson et al., 1998; Willett et al., 2001). We have used
the scl-PAC-GFP line transgenic line, along with DIC micro-
scopy, to follow the development of hematopoietic clusters in
this region. Immediately after the primitive erythroblasts have
entered circulation, the floor of the DA and the roof of the PCV
are closely apposed. By 2 dpf, isolated, round GFP-positive cells
are seen between the floor of DA and the roof of the PCV. During
the next 2 days, clusters of GFP-expressing cells form on the roof
of the PCV. These cells express a panel of hematopoietic markers
confirming their hematopoietic identity. The clusters are
surrounded by endothelial cells, which appear to be out-pockets
of the PCV endothelium. The most ventral cells of the hema-
topoietic clusters project into the lumen of the PCV, implying
that they enter circulation via the PCV. Two different treatments
to specifically ablate definitive hematopoiesis, TCDD treatment
and runx1 MO injection, both resulted in loss of the trunk
hematopoietic clusters. This implies that these clusters are,
indeed the site of initiation of definitive hematopoiesis. Strong
support for this conclusion is provided by the recent work of
Murayama et al. (2006), who show that laser activation of caged
fluorescein in the region between the DA and PCV at 2 dpf
results in labeling of cells in the thymus and pronephros at 5 dpf.
Interesting TCDD treatment and injection of runx1 MO
have slightly different phenotypes (Fig. 6), which suggest that
they block definitive hematopoiesis at different stages. Runx1
MO-injected embryos have no GFP-expressing cells between
the DA and PCV, and the distance between these vessels is
reduced. In contrast, in TCDD-treated embryos, the distance
between the DA and PCV is the same as in controls, and there
are GFP-expressing cells between the vessels. These GFP-
expressing cells have the morphology of endothelial cells.
These data imply that runx1 MO blocks definitive hematopoi-
esis at an earlier stage than TCDD, preventing the formation of
the GFP-positive cell population between the vessels. In
TCDD-treated embryos, this population does appear to be
generated, but is prevented from progressing along the
hematopoietic lineage and differentiates instead as endothelial
cells.
The clusters form adjacent to boundaries between somites. It
may be that the slight constriction in the width of somites at the
boundary provides a physical niche within which the clusters can
form. However, it is also possible that signals from the adjacent
somites act to pattern the formation of the clusters. Certainly,
signals from the somites are involved in regulating and guiding
the growth of blood vessels in the trunk (reviewed in Weinstein,
2005). For example signaling by semaphorins expressed in the
medial somite is involved in the guidance of the segmental
vessels that grow out from the DA at somite boundaries (Torres-
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the somites to position the hematopoietic clusters could act
through Notch. Notch signaling has been implicated in several
processes in blood cell development (reviewed in Ohishi et al.,
2003). It was recently shown in zebrafish that notch signaling is
necessary to maintain expression of hematopoietic markers in
the ventral part of the DA during the second day of embryonic
development (Burns et al., 2005), however, it was not clear what
was the source of the signal in these experiments. We therefore
intend to investigate the signals involved in the position of the
hematopoietic clusters in zebrafish.
The identity of the GFP-expressing hematopoietic cells in the
ventral tail is less clear. Treatment with TCDD or injection of
runx1 MO results in only a small reduction in their numbers.
This would imply that the majority of these cells are primitive
rather than definitive in character, and is consistent with the
sparse expression of runx1 in the tail. The possibility that there is
a second wave of primitive hematopoiesis is not without
precedent. In mice, the first wave of primitive, yolk sac, hema-
topoiesis consists of single-lineage erythroid or macrophage
progenitors (Palis et al., 1999). Similarly, in the zebrafish, the
first wave of blood cells consists of erythroid cells from the ICM
and primitive macrophages from the ALM. In mice, a later wave
of yolk sac hematopoiesis (which initiates prior to the seeding of
the yolk sac with definitive HSCs from the AGM) is mediated by
multilineage progenitors (Palis et al., 2001). Globin is expressed
in the ventral tail region of zebrafish after the first wave of
primitive erythroblasts has entered circulation (Quinkertz and
Campos-Ortega (1999), Figs. 4M, 5F), as are markers of
macrophages and granulocytes (Lieschke et al., 2001; Bennett
et al., 2001). This could imply that the ventral tail contains
primitive erythro-myeloid progenitors equivalent to those found
in the mouse yolk sac.
However, we do not believe that definitive hematopoietic
cells are absent from the ventral vein region. Markers associated
with definitive hematopoiesis, including c-myb (Thompson
et al., 1998), runx1 (albeit sparsely) and ikaros (Gering and
Patient, 2005), are also expressed by cells in the ventral tail after
circulation has begun. Furthermore, Murayama et al. (2006)
have recently shown that activation of caged fluorescein in the
tail at 2 dpf results in labeling of cells in the thymus and
pronephros at 5 dpf. We also have preliminary data that ablation
of the tail region results in a reduction in the number of rag1-
expressing thymocytes (our unpublished results). We would
therefore suggest that many, but not all, of the hematopoietic
cells in this region are primitive rather than definitive.
Similarities to, and differences from, amniote definitive
hematopoiesis
Our characterization of the formation of hematopoietic
clusters in zebrafish shows that definitive hematopoiesis initiates
in the anatomically homologous position to the AGM, the
probable site of the first generation of definitive HSCs in
amniotes. The ontogeny of HSCs in the AGM is still the subject
of some controversy. We believe that an interpretation that fits
most of the published data is that the HSCs are derived fromhemogenic endothelium in the ventral aspect of the DA. These
cells then enter the mesenchyme below the DA, mature and then
cross the ventral endothelium of the DA to form hematopoietic
clusters projecting into the vessel lumen. From here they seed, via
the circulation, the yolk sac, fetal liver and possibly other
hematopoietic sites such as the allantois and placenta. The
formation of the definitive clusters in zebrafish follows a similar
pattern. At 2 dpf, GFP-expressing round cells can first be seen
between the ventral floor of the DA and the roof of PCV. We
would predict that these cells are derived from the ventral
endothelium of the DA. This is both by analogy to amniotes, and
because of the expression of runx1, c-myb, and ikaros in the floor
of the zebrafish DA prior to their emergence (Gering and Patient,
2005). Until now, we have not been able to image zebrafish for
periods that are long enough to determine whether these cells are
indeed derived from the ventral DA. However, the recent
development of a culture system that allows prolonged timelapse
imaging of living zebrafish (Kamei and Weinstein, 2005) will
enable us to address this question. The clusters that then develop,
in zebrafish, cross the endothelium of the PCV (rather than the
DA as in amniotes) to project into the vessel lumen. From here,
they can enter circulation and, presumably, seed the site of later
hematopoiesis, the pronephros. A final difference from amniotes
is that, to our knowledge, there is no evidence that the
hematopoietic clusters in the DA of amniotes express markers
of terminal differentiation, whereas in the clusters in zebrafish,
there is clearly a subset of cells that express globin (Figs. 4L, 5F).
A second transgenic line that lacks hematopoietic enhancer(s)
We generated a second transgenic line, scl-6kUS-GFP, in
which GFP expression was driven by 6.25 kb of sequence
upstream of the transcription initiation site and which contained
the first (non-coding) exon and the first intron (Fig. 1C). This line
gave GFP expression in the CNS and endothelium identical to
that obtainedwith the scl-PAC-GFP line. GFPwas also expressed
in the PLM but GFP levels gradually fell in cells differentiating
into primitive erythrocytes while it was maintained in those that
became endothelium. In contrast, GFP expression was main-
tained in primitive erythrocytes in the scl-PAC-GFP line. Low-
level expression of GFP was detectable in primitive erythrocytes
throughout early embryogenesis in scl-6kUS-GFP transgenics.
In contrast, a recent study reported that a construct containing
3 kb of upstream sequence gave no expression in primitive
erythrocytes (Jin et al., 2006). This indicates that some positive
regulatory elements for primitive erythroid expression lie
between −6.25 kb and −3 kb but these are insufficient to
mediate the full level of expression. It has recently been shown in
mouse that an enhancer distal to MAP17 can mediate high-level
expression in primitive erythrocytes (Delabesse et al., 2005).
Since this gene is syntenic in zebrafish, and is present in the scl-
PAC-GFP construct, it is possible that an enhancer in a similar
position is responsible for the primitive erythroid expression of
zebrafish scl. The only non-coding sequences in the zebrafish
locus that have significant extended sequence similarity to other
vertebrate SCL loci are the proximal promoter, the first (non-
coding) exon, and RNA structural elements in the 3′UTR
192 X.Y. Zhang, A.R.F. Rodaway / Developmental Biology 307 (2007) 179–194(Gottgens et al., 2002). However, the expression pattern of the
scl-6kUS-GFP construct is strikingly similar to that of a mouse
construct containing 7 kb of upstream sequence along with the
non-coding exons (Sinclair et al., 1999). This implies that,
although sequence similarity cannot be detected beyond the
immediate promoter using current algorithms, the regulatory
potential of equivalent regions may be conserved.
The most striking feature of the scl-6kUS-GFP line is the lack
of GFP expression in the definitive clusters. This indicates that an
enhancer or enhancers necessary for expression in definitive
hematopoiesis are absent from this construct. We are currently
seeking to identify this enhancer in order to determine the tran-
scription factors responsible for expression of scl at the initiation
of definitive hematopoiesis. However, even without identifying
this enhancer, the two transgenic lines will provide a valuable
tool for identifying genes specifically expressed during the ini-
tiation of definitive hematopoiesis. GFP-expressing cells sorted
from the two lines will be used as sources of cDNA for com-
parison by gene-chip and subtractive hybridization to identify
genes specifically expressed in the hematopoietic clusters.
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